AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2021
Nov 24, 2021
34301_dirs_2021-11-24_dfa94489-6802-4c44-93a2-ddb8274ec624.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2021-11-11
Reporting Person: LaFrance Norman D. (CHIEF MEDICAL OFFICER)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-01 | Stock Option (right to buy shares of common stock) | $120000.00 | A | 120000 | Acquired | 2031-11-11 | Common Stock (120000) | Direct |
Footnotes
F1: 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26